Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editor's notes
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118507

The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study.

T Hamazaki, S Sawazaki, M Itomura, E Asaoka, Y Nagao, N Nishimura, K Yazawa, T Kuwamori, and M Kobayashi

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Hamazaki, T. in: JCI | PubMed | Google Scholar

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Sawazaki, S. in: JCI | PubMed | Google Scholar

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Itomura, M. in: JCI | PubMed | Google Scholar

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Asaoka, E. in: JCI | PubMed | Google Scholar

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Nagao, Y. in: JCI | PubMed | Google Scholar

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Nishimura, N. in: JCI | PubMed | Google Scholar

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Yazawa, K. in: JCI | PubMed | Google Scholar

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Kuwamori, T. in: JCI | PubMed | Google Scholar

The First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.

Find articles by Kobayashi, M. in: JCI | PubMed | Google Scholar

Published February 15, 1996 - More info

Published in Volume 97, Issue 4 on February 15, 1996
J Clin Invest. 1996;97(4):1129–1133. https://doi.org/10.1172/JCI118507.
© 1996 The American Society for Clinical Investigation
Published February 15, 1996 - Version history
View PDF
Abstract

41 students took either docosahexaenoic acid (DHA)-rich oil capsules containing 1.5-1.8 grams DHA/day (17 females and 5 males) or control oil capsules containing 97% soybean oil plus 3% fish oil (12 females and 7 males) for 3 mo in a double-blind fashion. They took a psychological test (P-F Study) and Stroop and dementia-detecting tests at the start and end of the study. The present study started at the end of summer vacation and ended in the middle of mental stress such as final exams. In the control group extraggression (aggression against others) in P-F Study was significantly increased at the end of the study as compared with that measured at the start (delta = +8.9%, P = 0.0022), whereas it was not significantly changed in the DHA group (delta = -1.0%). The 95% CI of differences between the DHA and control groups were -16.8 to -3.0%. DHA supplementation did not affect the Stroop and dementia-detecting tests. Thus, DHA intake prevented extraggression from increasing at times of mental stress. This finding might help understand how fish oils prevent disease like coronary heart disease.

Version history
  • Version 1 (February 15, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts